Showing results (1151-1160 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|June 9, 2022
Complete response and survival outcomes in patients with advanced cancer on immune checkpoint inhibitorsAdi Kartolo, Cynthia Yeung, Wilma Hopman, et al.Immunotherapy|June 9, 2022
Therapeutics to tackle Omicron outbreakVivek P Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M Yallapu, et al.Immunotherapy|June 13, 2022
Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB and PD-L1Daniel S Lefler, Adam E Snook, Babar BashirImmunotherapy|June 13, 2022
No association between BMI and immunotoxicity or clinical outcomes for immune checkpoint inhibitorsCynthia Yeung, Adi Kartolo, Ryan Holstead, et al.Immunotherapy|June 27, 2022
Safe use of intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer during breastfeeding: a case reportErol Barbur, Tunkut Doganca, Can ObekImmunotherapy|June 29, 2022
Immunology of osteoporosis: relevance of inflammatory targets for the development of novel interventionsSyed Sufian Ahmad, Faraha Ahmed, Ruhi Ali, et al.Immunotherapy|June 8, 2021
Current landscape of immunotherapy trials in locally advanced and high-risk head and neck cancerRobin Park, Jong Chul ParkImmunotherapy|June 2, 2021
Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological databaseEmilie Casarotto, Sheenu Chandwani, Laurent Mortier, et al.Immunotherapy|February 19, 2020
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancerCecilia Bozzetti, Anna Squadrilli, Rita Nizzoli, et al.Immunotherapy|July 7, 2021
Volume increase of spleen in melanoma patients undergoing immune checkpoint blockadeLaura Susok, Dominik Reinert, Carsten Lukas, et al.Pageof 190